Host immune determinants of stromal vascular fraction graft survival: Toward a concept of SVF therapy resistance — A systematic narrative review

From graft failure to regenerative failure

Despite the growing clinical use of SVF-based therapies, therapeutic outcomes remain highly heterogeneous across patients and indications. Traditionally, unsuccessful outcomes have been interpreted primarily through a technical perspective, including insufficient graft retention, inadequate harvesting procedures, poor vascularization, or suboptimal cell processing methods.^3,7,9 However, accumulating evidence suggests that regenerative failure cannot be explained solely by procedural variability and likely reflects a more complex interaction between the graft, the host microenvironment, and the biological properties of the SVF product itself.

Importantly, autologous SVF therapies differ fundamentally from conventional transplantation paradigms. Because the graft originates from the patient, classical alloimmune rejection mechanisms are largely absent. Nevertheless, transplanted tissues and cells remain exposed to intense inflammatory, ischemic, and metabolic stresses immediately after implantation. The success of engraftment therefore depends not only on cell survival but also on the capacity of the host environment to support vascular integration, immune resolution, and tissue remodeling.

In this context, regenerative failure should be viewed as a dynamic and multifactorial process rather than a simple absence of therapeutic efficacy. Early ischemic injury, dysregulated innate immune activation, impaired angiogenic adaptation, and altered stromal cell functionality may collectively compromise graft integration and long-term regenerative outcomes. Importantly, these mechanisms are likely interconnected and mutually reinforcing rather than isolated phenomena.

Defining “SVF therapy resistance”

We propose that the concept of “SVF therapy resistance” may provide a useful operational framework to characterize patients or biological contexts associated with reduced responsiveness to SVF-based regenerative therapies. The proposed interactions between innate immunity, hypoxia, angiogenesis, and host-related determinants contributing to SVF therapy resistance are summarized in Figure 2.OPEN IN VIEWER

SVF therapy resistance can be defined as: a state in which maladaptive host–graft interactions prevent effective engraftment, integration, or regenerative activity of autologous SVF-based therapies despite technically adequate cell delivery.

Importantly, this concept does not imply classical immune rejection. Instead, it reflects the inability of the local and systemic microenvironment to support regenerative processes following transplantation. Such maladaptive responses may involve excessive inflammation, defective angiogenesis, persistent hypoxia, endothelial dysfunction, impaired immune resolution, or intrinsic cellular dysfunction within the transplanted SVF product.

Proposed biological features distinguishing responders from non-responders to SVF-based therapies are summarized in Table 1.

OPEN IN VIEWER

Table 1.

Proposed features distinguishing responders and non-responders to SVF-based therapies.

Domain	Responders (effective engraftment)	Non-responders (SVF therapy resistance)
Early inflammatory response	Controlled neutrophil activation; efficient debris clearance	Excessive neutrophil activation; increased ROS and NET formation
Complement activation	Controlled activation	Exaggerated thrombo-inflammatory response
Neutrophil function	Transient response; limited cytotoxicity	Persistent activation; NET-mediated tissue damage and endothelial dysfunction
Macrophage polarization	Early transition toward M2 phenotype	Persistent M1-dominant inflammatory profile
Cytokine profile	Balanced pro- and anti-inflammatory signaling	Elevated pro-inflammatory cytokines (IL-6, TNF-α)
Angiogenesis	Rapid and efficient neovascularization	Impaired or delayed angiogenesis
Hypoxia response	Adaptive HIF-mediated response; restoration of perfusion	Persistent hypoxia; inadequate vascular adaptation
SVF cellular function	High regenerative potential; effective paracrine signaling	Reduced cellular potency; functional heterogeneity
Host inflammatory status	Low baseline inflammation	Chronic low-grade or systemic inflammation
Metabolic status	Metabolically balanced	Obesity, insulin resistance, metabolic dysfunction
Hormonal environment	Favorable hormonal balance	Altered hormonal status (e.g., estrogen imbalance)
Clinical outcome	Long-term graft retention; functional improvement	Graft resorption; poor or inconsistent outcomes

This framework may help explain why some patients exhibit limited clinical benefit despite apparently standardized procedures and adequate cell yields. It also provides a rationale for considering regenerative responsiveness as a biological continuum rather than a binary responder/non-responder state.

A multifactorial model of regenerative resistance

Current evidence suggests that regenerative outcomes in SVF therapy are influenced by at least four major interconnected domains:

(i) Host immune and inflammatory status

Baseline inflammatory tone, neutrophil activation, macrophage polarization dynamics, oxidative stress, and systemic inflammatory disorders may critically influence graft fate.^10–20

(ii) Angiogenic and microvascular competence

Successful graft integration requires rapid restoration of tissue perfusion. Impaired angiogenesis, endothelial dysfunction, and defective hypoxic adaptation may compromise graft survival.^8,21,22

(iii) Cellular quality and SVF heterogeneity

The regenerative properties of SVF products depend on complex and variable cellular compositions, including ADSCs, endothelial progenitors, immune cells, and stromal populations.^23–26 Aging, obesity, metabolic dysfunction, and chronic inflammation may alter these cellular functions.

(iv) Procedural and biophysical determinants

Mechanical trauma during harvesting, enzymatic digestion, endotoxin contamination, complement activation, oxygen diffusion limitations, and graft geometry may independently modulate inflammatory responses and cell viability.

Rather than acting independently, these domains likely interact continuously throughout the engraftment process. For example, impaired angiogenesis may exacerbate hypoxia, which in turn amplifies innate immune activation and promotes additional tissue injury. Similarly, poor cellular quality may reduce resilience to inflammatory stress and ischemic conditions.

Distinguishing technical failure from biological resistance

An important distinction should be made between:

• procedural or technical failure,

Technical failures may result from inadequate harvesting, poor injection technique, excessive mechanical stress, or insufficient cell viability. Product-related insufficiency may reflect altered SVF composition or low regenerative potency. In contrast, biological resistance refers to maladaptive host-graft interactions occurring despite technically adequate procedures and acceptable product quality.

This distinction is essential because it directly influences therapeutic strategies. While technical optimization may improve procedural consistency, overcoming biological resistance may require targeted modulation of inflammation, vascular responses, immune signaling, or cellular conditioning.

Toward precision regenerative medicine

The concept of SVF therapy resistance supports a transition from empirical regenerative approaches toward precision regenerative medicine. Rather than assuming equivalent responsiveness across patients, future strategies may require:

• pre-therapeutic immune profiling,

Such approaches may help identify patients at higher risk of therapeutic failure and facilitate the development of personalized interventions aimed at improving engraftment and regenerative efficacy.

Ultimately, understanding regenerative failure as a systems-level interaction between host biology, graft characteristics, and procedural determinants may provide a more realistic and clinically relevant framework for optimizing SVF-based therapies.

Early inflammatory responses following SVF grafting

Immediately after transplantation, adipose-derived grafts and SVF-containing products are exposed to profound ischemic and mechanical stress resulting from harvesting, processing, and implantation procedures. ⁷ This early injury phase leads to adipocyte disruption, extracellular matrix damage, and the release of danger-associated molecular patterns (DAMPs), thereby initiating a sterile inflammatory response within the graft microenvironment.

Although this inflammatory phase is necessary for tissue remodeling and debris clearance, excessive or dysregulated activation of innate immunity may critically compromise graft survival. The earliest stages of engraftment therefore represent a narrow biological window during which the balance between adaptive repair and uncontrolled inflammation determines long-term regenerative outcomes.

Importantly, innate immune activation after SVF transplantation does not occur in isolation but rather develops in a complex ischemic environment characterized by hypoxia, oxidative stress, endothelial dysfunction, and microvascular instability. These processes collectively shape the inflammatory landscape surrounding the graft.

Neutrophils and acute inflammatory injury

Neutrophils are among the first immune cells recruited to sites of tissue injury following fat grafting and SVF administration. ¹⁰ Their physiological role includes phagocytosis of necrotic debris, secretion of proteolytic enzymes, production of ROS, and orchestration of early antimicrobial defense mechanisms.

Experimental studies have demonstrated that disturbed neutrophil behavior during the early post-grafting period may negatively affect long-term graft retention. ¹⁰ Excessive neutrophil activation may amplify oxidative stress, damage endothelial structures, and exacerbate local ischemia. High ROS production can impair stromal cell viability, alter extracellular matrix integrity, and contribute to microvascular dysfunction.

Beyond simple inflammatory amplification, neutrophils may directly influence angiogenic responses. Excessive neutrophil-derived proteases and oxidants can disrupt endothelial integrity and impair neovascularization, thereby limiting oxygen and nutrient delivery to transplanted tissues during the critical early engraftment phase.

These observations suggest that neutrophil activity constitutes a central checkpoint in the balance between regenerative integration and inflammatory tissue injury.

Neutrophil extracellular traps (NETs) and sterile inflammatory toxicity

Among the mechanisms implicated in neutrophil-mediated tissue injury, neutrophil extracellular traps (NETs) have emerged as particularly relevant in regenerative contexts.^11–14 NETs are extracellular chromatin structures decorated with histones, proteases, and antimicrobial proteins released by activated neutrophils during a specialized process termed NETosis. ¹¹

Although NET formation contributes to antimicrobial defense, excessive NETosis has increasingly been implicated in sterile inflammatory diseases, thrombosis, endothelial injury, and microvascular dysfunction.^12–14 Experimental evidence suggests that NETs may impair tissue perfusion through several mechanisms, including:

• endothelial cytotoxicity,

In ischemic tissues, excessive NET formation may therefore critically compromise graft revascularization and oxygen delivery. NET-mediated obstruction of microcirculation may be particularly detrimental during the early post-transplantation period, when graft survival is highly dependent on rapid restoration of tissue perfusion.

Furthermore, NETs may contribute to persistent inflammatory amplification by sustaining macrophage activation and cytokine release. This creates a self-reinforcing inflammatory loop potentially unfavorable to regenerative integration.

Importantly, systemic conditions such as obesity, metabolic syndrome, diabetes, aging, and chronic inflammatory states have all been associated with altered neutrophil behavior and increased NET formation.^17,18,26 Such baseline inflammatory predispositions may partly explain inter-individual variability in regenerative responses following SVF therapies.

Processing-related inflammatory priming

In addition to host-related immune determinants, procedural and processing-related factors may independently contribute to inflammatory activation following SVF administration. Mechanical trauma during liposuction, enzymatic digestion, centrifugation, washing procedures, and resuspension media may alter both cellular integrity and the inflammatory profile of the final SVF product.^33,34

Importantly, tissue disruption and cell damage occurring during harvesting and processing can induce the release of damage-associated molecular patterns (DAMPs), thereby amplifying sterile inflammatory signaling independently of baseline host inflammatory status.^35–37 In parallel, residual endotoxin contamination or lipopolysaccharide (LPS) exposure introduced during enzymatic processing, washing solutions, or handling procedures may further activate innate immune pathways through Toll-like receptor 4 (TLR4)-mediated signaling. ³⁸

Even low-grade endotoxin exposure may enhance neutrophil activation, promote NETosis, stimulate pro-inflammatory macrophage polarization, and impair endothelial function and microvascular perfusion. In this context, mesenchymal stromal cells themselves may adopt distinct inflammatory phenotypes depending on environmental stimulation, shifting toward either pro-inflammatory (MSC1) or immunosuppressive (MSC2) functional states. ³⁹ Moreover, interactions between transplanted stromal cells and blood components may activate complement and coagulation cascades, contributing to thrombo-inflammatory responses after transplantation.^40,41 Similar inflammatory mechanisms have also been described in foreign body reactions to biomaterials and transplanted tissues. ⁴²

These observations suggest that inflammatory priming associated with SVF processing may partially contribute to the proposed concept of SVF therapy resistance and should be distinguished from purely host-mediated biological resistance mechanisms.

Macrophage polarization and tissue remodeling

Following the initial neutrophil-dominated phase, macrophages become the major orchestrators of tissue remodeling and inflammatory resolution. Macrophages exhibit remarkable functional plasticity and can adopt a broad spectrum of activation states depending on local environmental cues.^15,16

Classically activated M1 macrophages produce pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6, thereby promoting inflammatory amplification and tissue degradation. In contrast, alternatively activated M2 macrophages support tissue repair through:

• secretion of anti-inflammatory mediators,

The balance between M1 and M2 polarization appears to represent a major determinant of graft fate. Persistent M1-dominant inflammation is associated with chronic tissue injury, fibrosis, and graft resorption, whereas timely transition toward an M2-dominant environment promotes vascular integration and long-term tissue stability.^15,16

Importantly, macrophage polarization is strongly influenced by systemic host factors, including obesity, insulin resistance, metabolic dysfunction, hormonal status, and chronic low-grade inflammation.^17–20,25 Metabolic dysfunction may drive distinct pro-inflammatory macrophage phenotypes characterized by altered cytokine production and impaired reparative activity. ²⁵

These findings further support the concept that baseline host immune status may critically modulate regenerative responsiveness.

Crosstalk between innate immunity and angiogenesis

Innate immune responses and angiogenesis are closely interconnected processes during graft integration. Macrophages—particularly M2-like phenotypes—represent important sources of pro-angiogenic mediators including vascular endothelial growth factor (VEGF), transforming growth factor-β (TGF-β), and matrix remodeling enzymes.

Conversely, excessive neutrophil activation, NET formation, oxidative stress, and persistent inflammatory signaling may impair endothelial function and disrupt angiogenic processes. Thus, inflammatory dysregulation may indirectly compromise graft survival by limiting neovascularization.

The temporal coordination between inflammation and vascular remodeling therefore appears critical. Controlled inflammatory activation may support tissue adaptation and repair, whereas persistent or exaggerated innate immune responses may shift the microenvironment toward chronic injury and regenerative failure.

Innate immunity and the concept of SVF therapy resistance

Collectively, current evidence suggests that innate immunity should not be viewed merely as a secondary consequence of tissue transplantation but rather as a central regulator of SVF engraftment outcomes.

Variability in neutrophil activation, NET formation, macrophage polarization, oxidative stress responses, and inflammatory resolution mechanisms may create distinct host inflammatory phenotypes associated with differential regenerative capacity. In some patients, maladaptive innate immune responses may generate a persistently hostile microenvironment preventing effective graft integration despite technically adequate procedures and sufficient cell delivery.

Such observations support the hypothesis that dysregulated innate immunity constitutes one of the major biological foundations underlying the proposed concept of SVF therapy resistance.

Hypoxia as an unavoidable early stressor

Following transplantation, adipose tissue grafts and SVF-containing products are immediately exposed to a hypoxic environment due to disruption of their native vascular supply. ⁷ During the early post-implantation phase, oxygen and nutrient diffusion become critically limited, exposing transplanted cells to severe metabolic stress before adequate neovascularization can occur.

This ischemic period represents one of the principal bottlenecks of graft survival. Experimental studies have demonstrated that adipocyte death occurs rapidly after transplantation when vascular reconnection is insufficient. ⁷ Inadequate oxygenation promotes apoptosis, necrosis, lipid cyst formation, fibrosis, and progressive graft resorption. ⁸

Importantly, hypoxia should not be viewed solely as a deleterious phenomenon. Moderate and transient hypoxic exposure may activate adaptive cellular programs capable of supporting regenerative responses. In contrast, prolonged or severe ischemia may exceed the adaptive capacity of both grafted cells and host tissues, leading to irreversible tissue injury.

Thus, the biological outcome of hypoxia largely depends on the balance between adaptive vascular remodeling and persistent ischemic stress.

HIF signaling and adaptive angiogenic responses

Cellular adaptation to hypoxia is primarily mediated through stabilization of hypoxia-inducible factors (HIFs), which regulate the transcription of genes involved in angiogenesis, metabolism, cell survival, and tissue remodeling.^20,21

Among HIF-regulated mediators, vascular endothelial growth factor (VEGF) plays a central role in promoting neovascularization and restoration of tissue perfusion. VEGF stimulates endothelial proliferation, vascular permeability, and microvascular remodeling, thereby facilitating oxygen delivery to ischemic tissues.

Experimental studies have shown that hypoxic preconditioning of adipose-derived stromal cells may enhance:

• pro-angiogenic signaling,

Hypoxia-preconditioned ADSCs exhibit increased secretion of VEGF and other trophic mediators, suggesting that controlled activation of hypoxic pathways may represent a therapeutic strategy to improve engraftment.

However, excessive or prolonged hypoxia may instead trigger inflammatory amplification, mitochondrial dysfunction, oxidative stress, and apoptotic signaling. Consequently, successful graft integration depends not simply on hypoxic exposure itself but rather on the efficiency of adaptive angiogenic responses.

Angiogenesis and adipose tissue integration

Angiogenesis and adipogenesis are tightly interconnected biological processes. ⁸ Adequate vascularization is required not only for the survival of pre-existing adipocytes but also for the maintenance, differentiation, and metabolic activity of newly regenerated adipose tissue.

The establishment of a functional microvascular network therefore constitutes a decisive step in long-term graft integration. Rapid neovascularization supports:

• oxygen delivery,

Conversely, delayed or insufficient vascular adaptation results in persistent ischemia and progressive graft deterioration. Histologically, poorly vascularized grafts are frequently characterized by fibrosis, oil cyst formation, calcification, and chronic inflammatory infiltration.

Importantly, angiogenic efficiency may vary substantially between individuals. Aging, obesity, endothelial dysfunction, diabetes, smoking, and chronic inflammatory states have all been associated with impaired vascular regenerative responses.^17,25 Such host-related variability may critically influence the capacity to support graft integration after SVF transplantation.

Diffusion-limited ischemia and spatial graft heterogeneity

An additional but often underappreciated determinant of graft survival relates to the spatial organization and diffusion limitations within transplanted adipose tissue. SVF-containing grafts are structurally heterogeneous and may contain regions exposed to markedly different oxygenation conditions during the early post-transplantation period.

Cells located within the central core of dense graft clusters may experience prolonged ischemia before adequate neovascularization occurs. Because oxygen diffusion is limited to relatively short distances, central regions may undergo severe hypoxia, necrosis, and lipid degeneration despite apparently adequate peripheral vascularization. These necrotic zones may subsequently release DAMPs and inflammatory mediators, thereby amplifying innate immune activation and secondary tissue injury.

Importantly, diffusion-limited hypoxia may create a self-reinforcing loop linking ischemia, inflammation, endothelial dysfunction, impaired angiogenesis, and graft resorption. In this context, some manifestations currently interpreted as “host-mediated SVF therapy resistance” may partly reflect unfavorable graft architecture and biophysical constraints rather than exclusively immunological determinants.

These observations highlight the importance of considering graft geometry, cell density, and oxygen diffusion dynamics as additional modulators of regenerative outcomes.

Interactions between inflammation and angiogenesis

Inflammation and angiogenesis are deeply interconnected processes during regenerative tissue remodeling. Controlled inflammatory responses contribute to vascular adaptation by promoting endothelial activation and secretion of pro-angiogenic mediators.

Macrophages—particularly M2-like reparative phenotypes—represent key regulators of angiogenesis through the production of VEGF, TGF-β, matrix metalloproteinases, and extracellular remodeling factors.^15,16 In this context, properly coordinated immune activation may facilitate vascular integration and tissue repair.

In contrast, excessive inflammatory activation may severely impair microvascular adaptation. Persistent neutrophil activation, oxidative stress, endothelial injury, and NET formation may disrupt endothelial integrity and promote microvascular dysfunction.^10–14 NET-associated thrombosis and capillary obstruction may further compromise tissue perfusion during the critical early post-grafting period.

Thus, angiogenic failure may not only result from insufficient pro-angiogenic signaling but also from excessive inflammatory injury impairing vascular stability.

Biophysical constraints and oxygen diffusion limitations

Beyond biological signaling pathways, graft survival is also constrained by fundamental biophysical limitations. Oxygen diffusion within transplanted adipose tissue is intrinsically restricted, particularly in large graft volumes or densely packed cellular environments.

Cells located beyond effective oxygen diffusion distances may rapidly undergo hypoxic injury before vascular reconnection can occur. Consequently, graft geometry, injection technique, tissue dispersion, and local microarchitecture may substantially influence tissue viability independently of immune mechanisms.

Mechanical compression, elevated interstitial pressure, and impaired microcirculatory flow may further exacerbate ischemic stress. These factors suggest that regenerative outcomes depend not only on cellular composition and host biology but also on spatial and biophysical properties of the graft itself.

Importantly, these biophysical constraints may interact synergistically with inflammatory mechanisms. Hypoxia may amplify inflammatory signaling, while inflammation-induced endothelial dysfunction may worsen tissue ischemia, thereby creating self-reinforcing cycles of regenerative failure.

Angiogenic failure and SVF therapy resistance

Collectively, current evidence indicates that successful SVF engraftment critically depends on the ability to transition from an ischemic environment toward stable vascular integration.

Patients with impaired angiogenic competence, endothelial dysfunction, chronic inflammation, or defective hypoxic adaptation may exhibit reduced regenerative responsiveness despite technically adequate procedures. In such contexts, persistent ischemia may maintain a hostile microenvironment characterized by oxidative stress, inflammatory amplification, and progressive tissue injury.

These observations support the hypothesis that angiogenic insufficiency and defective microvascular adaptation constitute major mechanistic components of the broader framework of SVF therapy resistance.

Rather than representing isolated phenomena, hypoxia, inflammation, vascular remodeling, and cellular survival likely form an integrated biological network determining whether transplanted SVF products successfully integrate or undergo progressive regenerative failure.

Procedural injury as an underrecognized determinant of regenerative outcomes

Although host-related biological factors are increasingly recognized as critical determinants of SVF therapy efficacy, procedural variables may independently influence graft survival and inflammatory responses. SVF-based therapies involve multiple processing steps—including harvesting, aspiration, centrifugation, washing, enzymatic digestion, filtration, and reinjection—that can substantially affect cellular integrity and microenvironmental signaling.

Historically, procedural optimization has primarily focused on maximizing cell yield and viability. However, accumulating evidence suggests that tissue processing itself may actively shape inflammatory and regenerative responses. Mechanical stress, enzymatic exposure, biomaterial interactions, and contamination-related inflammatory signaling may all contribute to early graft injury independently of host baseline characteristics.

Consequently, regenerative failure should not be interpreted exclusively as a host-mediated phenomenon but rather as the result of dynamic interactions between:

• host biology,

Mechanical stress and tissue processing-related inflammation

Adipose harvesting and SVF preparation expose cells to substantial mechanical stress. Liposuction-induced shear forces, aspiration pressure, centrifugation, filtration, and repeated manipulation may induce cellular membrane disruption, mitochondrial injury, and extracellular matrix fragmentation.^33,34

These mechanical insults may lead to the release of intracellular contents and DAMPs, thereby amplifying sterile inflammatory signaling immediately after transplantation.^35,36 Damaged adipocytes and stromal cells may release:

• mitochondrial DNA,

Mechanical trauma may also alter endothelial integrity and impair the survival of fragile stromal cell populations. Excessive tissue manipulation has been associated with reduced adipocyte viability and impaired long-term graft retention in experimental and clinical studies. ³³

Importantly, tissue processing methods may differentially influence inflammatory activation. Enzymatic SVF isolation, mechanical fragmentation, and nanofat preparation generate products with distinct cellular compositions, extracellular matrix content, and inflammatory profiles. Such differences may partly explain variability in regenerative outcomes observed across studies and clinical applications. ³⁴

Enzymatic digestion and inflammatory signaling

Collagenase-based enzymatic digestion remains widely used for isolation of cellular SVF products. While enzymatic processing improves cell yield and facilitates stromal cell extraction, it may also modify extracellular matrix architecture and alter cellular interactions within the graft microenvironment.

Residual enzymatic activity, matrix degradation products, and altered cell-surface signaling may potentially contribute to inflammatory activation after transplantation. In addition, enzymatic digestion may remove structural extracellular matrix components that normally provide mechanical protection and trophic support to transplanted cells.

Importantly, mesenchymal stromal cells are themselves highly responsive to inflammatory stimuli. Toll-like receptor (TLR) signaling pathways, particularly TLR3 and TLR4, have been shown to modulate mesenchymal stromal cell immunoregulatory functions and alter their interaction with immune cells. ³⁸ Furthermore, exposure to inflammatory stimuli may polarize mesenchymal stromal cells toward distinct functional phenotypes, including pro-inflammatory or immunosuppressive states. ³⁹

These observations suggest that procedural inflammatory signals may directly influence the biological behavior of transplanted SVF cells and alter their regenerative potential.

Importantly, enzymatic and mechanical SVF products should not be considered biologically equivalent. Mechanically derived stromal vascular tissue (SVT) or nanofat preparations retain substantial extracellular matrix content and microstructural organization, whereas enzymatically isolated SVF represents a more dissociated cellular suspension. ⁴³ These differences may influence:

• cell survival,

Such distinctions may become particularly relevant in highly inflammatory environments such as spinal cord injury, where graft–host interactions are strongly influenced by tissue architecture and inflammatory priming.

Endotoxin contamination and innate immune priming

An additional underrecognized determinant of regenerative outcomes involves low-grade endotoxin exposure and non-sterile inflammatory signaling associated with tissue processing procedures.

Even minimal endotoxin contamination may strongly activate innate immune pathways through Toll-like receptor 4 (TLR4) and CD14 signaling, leading to amplification of:

• IL-6,

• TNF-α,

• ROS production,

• neutrophil activation,

• and macrophage polarization.

Importantly, mesenchymal stromal cells and adipose-derived stromal cells are highly sensitive to inflammatory priming. Exposure to inflammatory microenvironments may profoundly alter their immunomodulatory properties, cytokine secretion profiles, and extracellular vesicle signaling. ³⁹

Thus, regenerative therapies intended to suppress inflammation may paradoxically become sources of inflammatory activation when exposed to procedural contaminants or excessive tissue injury.

Although clinically significant contamination is uncommon under appropriate manufacturing conditions, low-level inflammatory priming may still contribute to inter-study variability and inconsistent therapeutic responses, particularly in already inflamed or ischemic tissues.

Complement activation and innate immune recognition

Following transplantation, SVF products may also interact directly with plasma proteins and complement pathways. Cellular surfaces, extracellular vesicles, matrix fragments, and damaged membranes may trigger complement activation and opsonization, thereby facilitating innate immune recognition.

Therapeutic mesenchymal stromal cells have been shown to activate complement cascades and interact dynamically with circulating blood components following administration. ⁴³ Similar mechanisms may occur after SVF transplantation and contribute to:

• neutrophil recruitment,

In highly vascularized environments, innate immune activation may resemble forms of instant blood-mediated inflammatory reaction (IBMIR), initially described in transplantation biology. ⁴⁰ Such reactions may impair microvascular perfusion and contribute to early graft injury.

Furthermore, adsorption of plasma proteins onto transplanted cellular products may generate a dynamic “protein corona” capable of modifying immune recognition and inflammatory signaling. More broadly, biomaterial-associated inflammatory responses have been shown to critically influence macrophage behavior and tissue integration processes. ⁴¹

Although these mechanisms remain insufficiently characterized in SVF-based therapies, they may represent important contributors to regenerative variability.

Resuspension media and microenvironmental modulation

The local physicochemical environment surrounding transplanted SVF products may further influence inflammatory and regenerative responses. Osmolarity, ionic composition, protein content, and carrier materials may all affect cellular viability and immune activation.

Different resuspension media—including saline, platelet-rich plasma, albumin-containing solutions, or biomaterial scaffolds—may differentially modulate:

• endothelial interactions,

• cytokine signaling,

• oxidative stress,

• and cell survival.

Similarly, local biomaterial properties may influence macrophage polarization and foreign-body responses. ⁴¹ Even subtle differences in injection matrices or carrier materials may therefore contribute to variability in regenerative outcomes.

These observations reinforce the idea that regenerative efficacy depends not only on cellular composition but also on the surrounding procedural microenvironment.

Procedural inflammation versus host-mediated resistance

A critical distinction should be made between:

• technical failure,

• procedure-induced inflammatory injury,

• product-related insufficiency,

• and true host-mediated regenerative resistance.

In many cases, therapeutic failure is likely multifactorial and results from overlapping contributions of these mechanisms. Excessive procedural trauma may amplify inflammatory signaling and worsen ischemic stress, thereby mimicking or exacerbating host-related resistance phenomena.

Consequently, the concept of SVF therapy resistance should not be interpreted as assigning therapeutic failure exclusively to patient biology. Instead, regenerative outcomes likely emerge from complex host–graft–procedure interactions occurring within highly dynamic inflammatory and vascular microenvironments.

Recognizing this complexity is essential for developing rational regenerative strategies. Optimizing procedural techniques, minimizing inflammatory priming, preserving cellular integrity, and controlling microenvironmental stressors may be just as important as host immune modulation itself.

Ultimately, integrating procedural determinants into the broader framework of SVF therapy resistance provides a more comprehensive and biologically coherent model of regenerative failure.